Own line of pharmabiotics
A systems approach to the microbiome: different groups of strains — different directions of action
Over a long period of time, our team conducted comprehensive microbiological studies, isolated and identified promising strains of microorganisms. Their probiotic properties were confirmed according to all selection criteria:
In vitro activity tests
Safety indicators
Stability in the composition of a food product and beyond
Preservation of beneficial properties throughout the entire shelf life
Our own probiotic collection, selected and researched by our team, includes the following strains of microorganisms:
Lactobacillus paracasei IMB B-7483
Lactobacillus plantarum IMB B-7414
Lactobacillus casei IMB B-7412
Lactobacillus plantarum IMB B-7413
Lactobacillus bulgaricus A6
Lactobacillus bulgaricus A22
Lactobacillus bulgaricus S6
Lactobacillus plantarum A
Lactobacillus rhamnosus S25
Lactobacillus delbrueckii subsp. bulgaricus S19
Enterococcus faecalis M4 II I
Our pharmabiotics
A pharmabiotic is simply a “probiotic/microbial product treated as a medicine”: it has a clearly demonstrated health benefit, confirmed by research. Our pharmabiotics are carefully selected and researched strains of microorganisms with proven beneficial properties. Each pharmabiotic has a clearly defined purpose of action: from supporting the intestinal microbiome to supporting skin, oral and genitourinary health.
Enterococcus faecalis M4-II-I
-
Pharmabiotics group: For skin health
-
Action goal: Support skin microbiome and barrier function
-
Main areas of application: Dermatological conditions associated with skin dysbiosis (atopic dermatitis, eczema, acne), skin barrier restoration, adjunct to dermatological therapy
Lactobacillus bulgaricus S6, Lactobacillus plantarum A, Lactobacillus delbrueckii subsp. bulgaricus S19
-
Pharmabiotics group: For the oral microbiome
-
Purpose of action: Balance of oral microflora, reduction of inflammation of mucous membranes
-
Main areas of application: Chronic gingivitis, stomatitis, periodontitis, recurrent oral candidiasis, addition to dental hygiene and treatment
Lactobacillus paracasei IMB B-7483, Lactobacillus plantarum IMB B-7414
-
Pharmabiotics group: For the microbiome of the genitourinary system
-
Purpose of action: Support of physiological microbiota, antibacterial and antifungal action
-
Main areas of application: Comprehensive programs to support urogenital health, control of opportunistic biota, preventive and supportive regimens
Lactobacillus casei IMB B-7412, Lactobacillus plantarum IMB B-7413
-
Pharmabiotics group: For children (oral cavity + intestine)
-
Action goal: Comprehensive support of the oral and intestinal microbiome
-
Main areas of application: Prevention of diseases of the oral mucosa and early caries associated with gastroduodenal disorders; support of digestion in children
Lactobacillus bulgaricus A6, A22, S6; Lactobacillus rhamnosus S25
-
Pharmabiotics Group: For the Gut Microbiome and Digestion
-
Objective: Normalization of intestinal microbiota and motility, reduction of dyspepsia symptoms
-
Main areas of application: Bloating, diarrhea, constipation, chronic inflammatory processes in the intestines, digestive support, weight control programs
144
publications
64
articles
18
chapters / books
For manufacturers and B2B partners
Our pharmabiotics are designed for companies working with health products:
from food products and dietary supplements to cosmetics and comprehensive microbiome-focused solutions.
We cooperate with manufacturers:
Food products and functional beverages
Dietary supplements, nutraceuticals, weight control products
Cosmetics and dermocosmetics (skin care, oral care, etc.)
Other products where scientifically proven effects on the microbiome are important
What we offer to partners:
Ready-made pharmabiotic complexes
for different product categories
Development of individual formulas
for your technology and target audience
Scientific and technical support
dosage, compatibility with the recipe, technological modes
Technical documentation package
on strains and compositions (origin, characteristics, stability)
Product co-development
and support in communicating scientific value to professional audiences.
